Pharmacokinetic/Pharmacodynamic Modeling of Luteinizing Hormone (LH) Suppression and LH Surge Delay by Cetrorelix after Single and Multiple Doses in Healthy Premenopausal Women
暂无分享,去创建一个
Hartmut Derendorf | Robert Hermann | Mathias Locher | Nelamangala V Nagaraja | Birgit Pechstein | Katharina Erb | Christine Klipping
[1] R. Frydman,et al. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). , 2000, Fertility and sterility.
[2] D. Klingmüller,et al. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. , 1994, Human reproduction.
[3] J. Veldhuis,et al. Reanalysis of the rat proestrous LH surge by deconvolution analysis. , 1993, The American journal of physiology.
[4] D. Klingmüller,et al. Seven-day administration of the gonadotropin-releasing hormone antagonist Cetrorelix in normal cycling women. , 1994, European journal of endocrinology.
[5] H. Tournaye,et al. Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles. , 1999, Human reproduction.
[6] A. Schueler,et al. Pharmacodynamic effects and plasma pharmacokinetics of single doses of cetrorelix acetate in healthy premenopausal women. , 2001, Fertility and sterility.
[7] B. Szende,et al. Development of radioimmunoassay for a potent luteinizing hormone-releasing hormone antagonist. Evaluation of serum levels after injection of [Ac-3-(2-naphthyl)-D-Ala1, D-Phe(pCl)2, 3-(3-pyridyl)-D-Ala3, D-Cit6, D-Ala10] LHRH. , 1990, Arzneimittel-Forschung.
[8] ASTA-Medica Ag. Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist Cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study , 2000 .
[9] Varun Garg,et al. Comparison of four basic models of indirect pharmacodynamic responses , 1993, Journal of Pharmacokinetics and Biopharmaceutics.
[10] K. Diedrich,et al. Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages , 1996, Journal of Assisted Reproduction and Genetics.
[11] R. Frydman,et al. A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge. , 1994, Fertility and sterility.
[12] T. Soboleva,et al. A model of follicular development and ovulation in sheep and cattle. , 2000, Animal reproduction science.
[13] William Francis Ganong,et al. Review of Medical Physiology , 1969 .
[14] Contemporary aspects of discrete peak-detection algorithms. I. The paradigm of the luteinizing hormone pulse signal in men. , 1988, Endocrine reviews.
[15] G. De Nicolao,et al. Evaluation of pulse-detection algorithms by computer simulation of hormone secretion. , 1988, The American journal of physiology.
[16] M L Johnson,et al. Contemporary aspects of discrete peak-detection algorithms. II. The paradigm of the luteinizing hormone pulse signal in women. , 1992, Endocrine reviews.
[17] M. Grigat,et al. Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study. , 2000, Human reproduction.
[18] S. Moenter,et al. Gonadotropin-releasing hormone requirements for ovulation. , 1997, Biology of reproduction.
[19] R. Hermann,et al. Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers. , 1998, Human reproduction.
[20] H. Derendorf,et al. Pharmacokinetic and pharmacodynamic modeling of cetrorelix, an LH‐RH antagonist, after subcutaneous administration in healthy premenopausal women , 2000, Clinical pharmacology and therapeutics.
[21] M L Johnson,et al. The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[22] M L Johnson,et al. A novel general biophysical model for simulating episodic endocrine gland signaling. , 1988, The American journal of physiology.